Dr. Apostolia Tsimberidou from MD Anderson Cancer Center on the Next Steps for Personalized Care
Apostolia M. Tsimberidou, MD, PhD, of the University of Texas MD Anderson Cancer Center, explains the next steps for personalized cancer care. She believes it involves continuing to test patients for molecular aberrations and selecting the correct patients for early drug development.
Tsimberidou states there is still a need to understand the emergence of resistance to targeted therapies and the complexities of targeting more than one aberration or using the combination of multiple targeted therapies. She mentions MD Anderson Cancer Center's goal is for personalized treatments to be fully reimbursed and for it to become the standard of care in the future.